SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001759425-24-000023
Filing Date
2024-06-06
Accepted
2024-06-06 16:38:26
Documents
13
Period of Report
2024-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mirm-20240605.htm   iXBRL 8-K 41985
  Complete submission text file 0001759425-24-000023.txt   166009

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20240605.xsd EX-101.SCH 1901
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20240605_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20240605_pre.xml EX-101.PRE 12508
16 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20240605_htm.xml XML 2876
Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 241026047
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)